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Abstract 
Objectives: Prophylactic oral calcium supplement has been proposed in patients undergoing thyroidectomy in order to 
decrease incidence of postoperative hypocalcemia, and the duration of hospital stay. This study aimed to assess the 
effects of prophylactic oral calcium in patients undergoing total or subtotal thyroidectomy. 
Methods: Forty three patients who were scheduled for total and subtotal thyroidectomy, were randomly allocated to the 
case (n=23) and control (n=20) groups. Oral calcium carbonate (1 gram q 8 hours) was given to the patients in the case 
group starting 12 hours before surgery till 7 days post thyroidectomy. Clinical symptoms of hypocalcemia and 
postoperative calcium levels were compared between the two groups.   
Results: The mean postoperative calcium level 12 hours after surgery was not statistically different between the two 
groups (8.9±0.5 vs. 8.5±0.7, p=0.092); while after 24 hours, calcium level was significantly lower in the control group 
(8.9±0.5 vs. 8.4±0.8, p=0.037). The number of patients who had paresthesia was significantly higher in the control group 
than case group, at both 12 hours (p=0.02) and 24 hours postoperatively (p=0.04). Duration of hospitalization was 
significantly lower in the case group compared to the control group (p=0.006). 
Conclusions: Prophylactic oral calcium supplementation decreases the hypocalcemia related paresthesia after 
thyroidectomy and shortens duration of hospital stay.  
Citation: Ghafouri A, Shirangi S, Mohseni Sh, Shojaiefard A, Khorgami Zh, Hedayat A. Prophylactic Oral Calcium 
Reduces Symptomatic Hypocalcemia in Patients undergoing Total or Subtotal Thyroidectomy: a 
Randomized Controlled Trial. Acad J Surg, 2014; 1(3-4): 40-44. 
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Introduction 
The rate of hypocalcemia after bilateral 
thyroidectomy ranges from 0.5 to 50% (1), and 
permanent hypocalcemia occurs in 0.4-13.8% cases 
after thyroid surgery (2,3). 
Several studies have attempted to recognize the 
factors that would predict the development of post 
thyroidectomy hypocalcemia (2,4-12), however its 
prediction is still impractical. 
Some studies have proposed routine administration 
of oral calcium and/ or vitamin D in patients undergoing 
total thyroidectomy in order to reduce the likelihood of 
transient symptomatic hypocalcemia, and shorten the 
hospitalization period. 
Bellantone et al. (13) assessed the effect of calcium 
and also calcium plus vitamin D administration in this 
group of patients. They showed that both of these 
protocols effectively decrease the rate of symptomatic 
hypocalcaemia. Tartaglia et al. (14) studied the effect of 
calcitriol and oral calcium in more than 200 patients 
with total thyroidectomy. They also showed that 
prophylactic administration of calcitriol (1 microgram 
twice a day) and oral calcium (500 milligram 3 times 
per day) significantly reduces the risk of severe 
postoperative hypocalcaemia. Uruno (15) from Japan 
reported similar results with intravenous calcium 
administration. 
In this study, we evaluated the effect of prophylactic 
administration of oral calcium in patients undergoing 
total or subtotal thyroidectomy to determine the 
efficacy of prophylactic administration of oral calcium 
for reduction of post-thyroidectomy hypocalcemia. 
Materials and Methods 
Forty-three consecutive patients who were 
candidate for total or subtotal thyroidectomy were 
included in this prospective double-blinded randomized 
clinical trial. The study was performed from November 
2012 to Jun 2013.  Informed consent was obtained from 
all of the participants, and the study protocol was 
approved by the Ethical Committee of Tehran 
University of Medical Sciences. 
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Initially, a randomization list was prepared by the 
randomization software. Patients were randomly 
assigned to case (A) and control (B) groups through 
opening the sealed envelope by the research coordinator 
at the end of surgery. Patients requiring total or subtotal 
thyroidectomy due to multinodular goiter or thyroid 
cancer were consecutively enrolled into the study and 
were randomly assigned to either receive prophylactic 
oral calcium or not receive any prophylactic calcium. 
Serum albumin, calcium, phosphorous, creatinine and 
BUN levels were measured before surgery. Serum 
calcium was measured serially after surgery. 
Hypocalcemia symptoms were monitored, and need to 
intravenous calcium and hospital stay were recorded. 
We performed subtotal thyroidectomy for 
multinodular goiter if there was normal thyroid tissue at 
the base otherwise we performed total thyroidectomy. 
Total thyroidectomy was also performed in Grave’s 
disease and thyroid cancer. In cancer patients, we 
performed central lymph node dissection in all cases 
and lateral lymph node dissection if indicated. We 
routinely localized parathyroid glands during the 
surgery and preserved them. There was no accidental 
parathyroid removal or autotransplantation in our 
patients. 
Patients in the case group (A) received calcium 
carbonate orally (1 g at 10 PM and 6 AM before the 
surgery in the morning), and 1 g every 8 hours after the 
surgery for one week. Control group (B) did not receive 
calcium supplements. Calcium levels were checked at 1 
and 12 hours after surgery and also calcium and 
phosphorus were measured in the morning of first 
postoperative day. All Patients were evaluated for the 
signs and symptoms of hypocalcemia by a trained nurse 
every 4 hours after surgery, and the data registered in 
data collection forms. 
If hypocalcemic symptoms such as perioral or acral 
paresthesia, tingling or Chvostek sign appeared in case 
group, they were infused 10 ml intravenous calcium 
gluconate 10% slowly over 30 minutes. In control 
group with mild symptoms calcium carbonate were 
administered with the dose of 500-1000 mg every 8 
hours and if more severe symptoms such as carpopedal 
spasm developed or calcium level was less than 7.5 
mg/dl then 10 ml of intravenous calcium gluconate 10% 
was infused slowly and was repeated if necessary. 
Frequency of clinical and laboratory hypocalcemia and 
intravenous calcium administration were recorded. 
All patients were discharged 48 hours after surgery 
when calcium level was more than 7.5 mg and they did 
not have hypocalcemic symptoms and surgical 
complications. 
For both groups calcium levels were checked one 
week postoperatively and they were followed at surgery 
clinic. Patients were advised to immediately call the 
physician or come back to the hospital emergency room 
whenever symptoms of hypocalcemia developed after 
discharge. Hypocalcemic symptoms, extra calcium 
administration, i and readmissions were recorded. 
Statistical analyses were performed using SPSS for 
windows (version 17; SPSS Inc., Chicago, IL, USA). 
The normality of variables was analyzed according to 
Kolmogorov–Smirnov test. Variables in normal 
distribution were analyzed with Student’s t-test and the 
other variables were analyzed by nonparametric tests 
(Mann–Whitney U test). Sequential change of 
quantitative variables between two groups was 
analyzed using repeated measures ANOVA test. P-
values less than 0.005 were considered as significant. 
Results 
Among 43 consecutive patients, 23 (53.5%) 
received oral calcium before thyroidectomy (case 
group), and 20 (46.5%) did not receive calcium (non-
calcium group). Mean age of the patients was 40.9±11 
(17 - 61 years). There was no difference in age, gender, 
and indication of surgery between the two groups 
(p>0.05), which indicate to the random validity of the 
study (Table 1). 
In calcium group, 14 (60.9%) patients underwent 
total thyroidectomy and for 9 (39.1%) patients subtotal 
thyroidectomy was performed. In non-calcium group 
Table 1. Comparison of mean age and patients’ distribution according to the etiology and surgery type between case and groups. 
Variables Calcium group 
(n=23) 
Non-calcium group 
( n=20) 
P  
Age (year) 41.48±11.7 42.6±9.5 0.73 
Male gender 6 (26.1%) 5 (25%) 0.86 
Etiology of surgery 
0.63 
Graves’ disease 3 (13%) 1 (5%)
Thyroid cancer 5 (21.7%) 4 (20%)
Multinodular goiter 15 (65.2%) 15 (75%) 
Surgery type 
0.36 Total thyroidectomy 14 (60.9%) 9 (45%) 
Subtotal thyroidectomy 9 (39.1%) 11 (51%) 
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the operative procedures were total thyroidectomy for 9 
(45%) patients and subtotal thyroidectomy for 11 (51%) 
patients; no statistical differences was found between 
the two groups (p=0.36) with regard to surgical 
procedure type (Table1). The mean calcium level 12 
hours after surgery was higher in calcium group than in 
non-calcium group but not statistically significant 
(8.9±0.5 vs. 8.5±0.7 mg/dl, p=0.092). The mean 
calcium level in the morning of postoperative day was 
significantly higher in calcium group than in non-
calcium group (8.9±0.5 vs. 8.4±0.8, p=0.037). 
Paresthesia was also experienced significantly less 
frequent by calcium group than non-calcium group at 
12 hours (2 (8.7%) vs. 8 (40%), p=0.02) and 24 hours 
after surgery (1 (4.3%) vs. 6 (30%), p=0.04) (Table-2). 
No difference was detected between the two groups in 
relation to paresthesia at 6h after surgery, Chvostek sign 
and carpopedal spasm 6, 12, and 24 hours after surgery. 
Serum calcium level at 1 week after surgery was also 
comparable. The need for intravenous calcium infusion 
during hospitalization was lower in calcium group than 
non-calcium group (2 (8.6%) vs. 10 (50%) which was 
statistically significant p=0.003). 
Twenty patients (87%) in calcium group were 
discharged 1 day after surgery, whereas 11 (55%) 
patients of non-calcium group discharged 1 day after 
surgery which was significantly different between the 
two groups (p=0.02). Calcium measured one week after 
surgery was 9.1±0.6 mg/dl in the calcium group and 
8.7±0.5 mg/dl in non-calcium group (p=0.007). 
Comparison of changes in serial serum calcium levels 
between the two groups was performed using Repeated 
Measures ANOVA which indicated that there was 
statistically significant differences between the two 
groups (p=0.024). 
Discussion 
Hypocalcemia is a major concern following thyroid 
surgery and occurs in up to one-third of patients 
following thyroidectomy. Although 97% of cases are 
self-limiting, if parathyroid glands removed 
inadvertently or damaged irreversibly, hypocalcemia 
remains permanently and can cause significant and 
serious clinical symptoms and raises the medical costs 
(16,17). Patients undergoing thyroidectomy should be 
monitored carefully for hypocalcemia and should be 
treated by oral or intravenous infusion of calcium to 
relieve symptoms and prevent related complications. 
Typically, symptoms of transient hypocalcaemia occur 
24 to 48 hours after surgery (13). Perioral paresthesia, 
and other mild symptoms of hypocalcaemia, can be 
treated with oral calcium intake. More severe signs such 
as carpopedal spasm require prompt intravenous 
infusion of calcium followed by oral calcium and 
activated form of vitamin D (calcitriol) (18). 
Various factors may account for an increased risk of 
hypocalcemia, including Graves’ disease, older age, 
poor surgical technique, hemodilution, and increased 
urinary calcium excretion secondary to surgical stress. 
On the contrary, increasing surgeon’s experience can 
decrease the risk (1,19-21). Recently it has been shown 
that preoperative serum vitamin D deficiency is an 
independent risk factor for hypocalcemia following 
total thyroidectomy although it only increases the risk 
of transient hypocalcemia (19,20,22). 
Several strategies have been anticipated for 
conserving calcium level after thyroidectomy. To 
decrease the symptoms of hypocalcemia, some 
surgeons prefer to prescribe oral calcium 
prophylactically, whereas others prefer to treat patients 
with postoperative hypocalcemia. They routinely check 
hypocalcemia symptoms in postoperative period and 
measure serum calcium. Also, they educate patients on 
Table 2. Comparison of hospitalization period, mean calcium level 12 and 24 hour post-surgery and intravenous calcium 
requirement in calcium and non-calcium groups. The data is described in the form of amount and “mean±standard deviation”. 
Variable calcium group 
(n=23) 
non-calcium group 
(n=20) 
* P
Hospitalization    
Period (day) 
2.1±0.3 2.9±1.4 0.006
Mean calcium level 
one hour post-surgery 
8.9±0.6 8.8±0.4 0.971
Mean calcium level 
12 h post-surgery 
8.9±0.5 8.5±0.7 0.092
Mean calcium level 
24 h after surgery 
8.9±0.5 8.4±0.8 0.037
Calcium level one       
week after surgery 
9.1±0.6 8.7±0.5 0.007
Paresthesia 12 h   
After surgery(patient) 
2(8.7%) 8(40%) 0.02
Paresthesia 24h    
After surgery(patient) 
1(4.3%) 6(30%) 0.04
Calcium intravenous        
Requirement 
2(8.6%) 10(50%) 0.003
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the symptoms of hypocalcemia while discharging them. 
Park et al. (16) demonstrated that administration of oral 
calcium and vitamin D reduces the incidence and 
severity of hypocalcaemia after total thyroidectomy. 
Moore (23) showed that oral calcium administration 
may lead to sooner discharge on the second 
postoperative day (36 hours after Surgery) without 
hypocalcaemia attack. Sanabria (24) evaluated four 
randomized clinical trials in a meta-analysis. They 
found that administration of calcium and vitamin D 
supplements decreases the incidence of hypocalcaemia 
symptoms after thyroidectomy. 
The main preventive measure is preserving 
parathyroid glands by careful dissection during the 
surgery; also parathyroid autotransplantation has been 
campaigner as another resolution to prevent permanent 
hyperparathyroidism after total, subtotal, or completion 
thyroidectomy for benign or malignant diseases of the 
thyroid. It has been reported that patients who received 
parathyroid autotransplantation had a significantly 
lower risk of permanent hyperparathyroidism once 
postoperative hypocalcemia occurred (25,26). Abboud 
et al. (27) performed a retrospective study on 252 
patients who underwent total thyroidectomy. They 
found that routine autotransplantation of at least 1 
parathyroid gland along with routine calcium and 
vitamin D supplementation during total thyroidectomy 
efficiently reduced symptomatic hypocalcemia and 
permanent hyperparathyroidism. 
In the present study it was shown that administration 
of oral calcium supplements, starting the night before 
surgery and continuing postoperatively every 8 hours, 
would significantly decrease symptomatic 
hypocalcaemia after total or subtotal thyroidectomy. 
In spite of normal ranges of serum calcium level in 
two groups 24 hours after surgery, the difference was 
statistically significant between two groups. Although 
calcium values were between 8.5-10.5 in two groups 
but it was lower in non-calcium group and the rate of 
hypocalcemia symptoms was significantly higher in 
non-calcium group with more perioral and/or limb 
paresthesia 12-24 hours after surgery. 
Another finding in this study was that the number of 
patients requiring intravenous calcium was 
significantly lower in calcium group (8.6% vs. 50%). It 
can be suggested that prophylactic oral calcium reduces 
the need for calcium injections after total or subtotal 
thyroidectomy. 
Considering the administration of prophylactic oral 
calcium supplementation reduces the symptoms of 
hypocalcemia 24 hours after surgery; thus, patients can 
be discharged within 24 hours. It should be borne in 
mind that the prophylactic dose of calcium (1 g of 
calcium carbonate every 8 hours) with or without 
calcitriol could prevent the development of symptoms 
of hypocalcaemia after thyroidectomy. 
This study had some limitations. Low number of 
patients and possible low power of findings are of the 
limitations mandating further studies and later meta-
analysis. Also, we did not study serum intact 
parathyroid hormone and other related markers to 
calcium homeostasis. 
In conclusion, prophylactic oral calcium 
supplementation therapy reduces the incidence of 
symptomatic hypocalcemia and the need for calcium 
infusion 24 hours after total or subtotal thyroidectomy. 
It may also allow the patient discharge from the hospital 
earlier. 
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